Entering Late into the COVID-19 Vaccine Race, Could this Pharma Duo Measure up to Competition?
By T. Chakraborty, Ph.D. As of September, COVID-19 has affected over 26 million people, claiming approximately 880,000 lives, while rendering millions with unknown neurological-effects. Biopharma companies around the world are …
Read More